Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Lung Cancer (Amsterdam, Netherlands)|October 19, 2010
S-1 is an active anticancer agent for advanced thymic carcinomaYusuke Okuma, Tsuneo Shimokawa, Yusuke Takagi, et al.
Cancers|March 28, 2024
Patterns and Incidence of Pneumonitis and Initial Treatment Outcomes with Durvalumab Consolidation Therapy after Radical Chemoradiotherapy for Stage III Non-Small Cell Lung CancerMizuki Sato, Kazumasa Odagiri, Yuya Tabuchi, et al.
BMC Pulmonary Medicine|January 10, 2022
Concurrent chemoradiotherapy with cisplatin + S-1 versus cisplatin + other third-generation agents for locally advanced non-small-cell lung cancer: a meta-analysis of individual participant dataYuri Taniguchi, Hiroaki Okamoto, Tsuneo Shimokawa, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 16, 2010
[Re-treatment with epidermal growth factor receptor tyrosine kinase inhibitor(EGFR-TKI)for lung adenocarcinoma]Shingo Miyamoto, Yusuke Ohkuma, Yusuke Takagi, et al.
Japanese Journal of Clinical Oncology|October 22, 2014
A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201)Junko Eba, Tsuneo Shimokawa, Kenichi Nakamura, et al.
BMC Cancer|October 24, 2018
Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutationsNaoto Aiko, Tsuneo Shimokawa, Kazuhito Miyazaki, et al.
Investigational New Drugs|August 6, 2022
An open-label, crossover study to compare different formulations and evaluate effect of food on pharmacokinetics of pimitespib in patients with advanced solid tumorsYoshito Komatsu, Tsuneo Shimokawa, Kohei Akiyoshi, et al.
Investigational New Drugs|August 18, 2020
Phase I/II study of erlotinib plus S-1 for patients with previously treated non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 0808/0913Yoshiro Nakahara, Tsuneo Shimokawa, Yuki Misumi, et al.
Cancer Chemotherapy and Pharmacology|May 9, 2012
A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI)Naoya Hida, Hiroaki Okamoto, Yuuki Misumi, et al.
International Journal of Clinical Oncology|February 20, 2009
Retrospective analysis of efficacy and safety of amrubicin in refractory and relapsed small-cell lung cancerTsuneo Shimokawa, Masahiko Shibuya, Kazuhiro Kitamura, et al.
Pageof 5